Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025)
Smith & Nephew (SNN) posted quarterly Cash & Current Investments of $577.0 million for Q4 2025, down 13.36% year-on-year from $666.0 million in Q4 2024, and down 14.64% on a QoQ basis from $676.0 million in Q2 2025.
Smith & Nephew (SNN) Cash & Current Investments (2009 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Cash & Current Investments for 17 consecutive years, with $577.0 million the latest figure, recorded in Q4 2025.
- Quarterly Cash & Current Investments fell 13.36% year-over-year to $577.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $577.0 million (down 13.36% YoY) and the FY2025 annual result came in at $577.0 million, down 13.36% from the prior year.
- Cash & Current Investments eased to $577.0 million in Q4 2025 per SNN's latest filing, from $676.0 million in the prior quarter.
- Over the last five years, Cash & Current Investments for SNN reached as high as $1.3 billion in Q4 2021 and fell as low as $329.0 million in Q4 2023.
- A 5-year average of $648.9 million and a median of $577.0 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments plunged 70.13% — and 2024, when it soared 102.43%.
- Year by year, Cash & Current Investments stood at $1.3 billion in 2021, then tumbled by 70.13% to $397.0 million in 2022, then dropped by 17.13% to $329.0 million in 2023, then soared by 102.43% to $666.0 million in 2024, then dropped by 13.36% to $577.0 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $577.0 million, $676.0 million, and $666.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 439.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 577.00 Mn |
| Jun 28, 2025 | 676.00 Mn |
| Dec 31, 2024 | 666.00 Mn |
| Jun 29, 2024 | 568.00 Mn |
| Dec 31, 2023 | 329.00 Mn |
| Dec 31, 2022 | 397.00 Mn |
| Dec 31, 2021 | 1.33 Bn |
| Dec 31, 2020 | 1.79 Bn |
| Jun 30, 2020 | 347.00 Mn |
| Dec 31, 2019 | 283.00 Mn |
| Jun 29, 2019 | 137.00 Mn |
| Dec 31, 2018 | 370.00 Mn |
| Jun 30, 2018 | 99.00 Mn |
| Dec 31, 2017 | 183.00 Mn |
| Dec 31, 2016 | 86.00 Mn |
| Dec 31, 2015 | 135.00 Mn |
| Jun 30, 2015 | 88.00 Mn |
| Dec 31, 2014 | 65.00 Mn |
| Sep 30, 2014 | 147.00 Mn |
| Jun 28, 2014 | 140.00 Mn |